Terence Lin, MD
Interventional Cardiology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 10
Offices
10 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A88330 · Current
Licensed to practise in California · since 2004 · expires 2028-02-29 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$206,629
Medicare paid this office $206,629 for 1,423 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 231 | $35,593 | $110 |
| Long return visit (40+ min) | 136 | $30,324 | $161 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $28,800 | $193 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | $15,043 | $456 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,526 | $232 |
See all 29 services
| Return visit (30+ min) | 231 | $35,593 | $110 |
| Long return visit (40+ min) | 136 | $30,324 | $161 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 148 | $28,800 | $193 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | $15,043 | $456 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $9,526 | $232 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,709 | $428 |
| New patient visit (60+ min) | 40 | $7,617 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $5,682 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 644 | $5,233 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,081 | $149 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 82 | $4,979 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 212 | $4,003 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 214 | $2,796 | $13 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,562 | $233 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $2,547 | $150 |
| Heart muscle strain imaging | 50 | $1,969 | $39 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $1,931 | $62 |
| Programming of dual lead pacemaker system | 14 | $1,628 | $71 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 55 | $1,205 | $22 |
| Injection, perflutren lipid microspheres, per ml | 19 | $921 | $32 |
| Short return visit (20+ min) | 12 | $812 | $68 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 61 | $690 | $10 |
| Heart rhythm recording of continous external ekg over 8-15 days | 52 | $656 | $13 |
| 3d radiographic procedure | 22 | $589 | $26 |
| Injection, regadenoson, 0.1 mg | 29 | $511 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 32 | $462 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $331 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $290 | $26 |
| Ultrasound of heart, follow-up | 11 | $241 | $22 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 26 | More than 59% of doctors who do this |
| Pacemaker insertion or repair | 14 | More than 65% of doctors who do this |
Who their Medicare patients are
1,423 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 23% · Women 51% · Also on Medicaid 34% · Health risk score 1.80. Above the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Diabetes 45% · Chronic kidney disease 37% · Atrial fibrillation 33% · Heart failure 31% · Depression 19% · COPD 18% · Cancer 15% · Dementia 14% · Stroke 13%.
The office billed $1,025,608, Medicare allowed $273,321 and paid $206,629; for 3,062 services of 91 kinds; $1,747 of it was for drugs given in the office and $204,882 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,423 | 3,062 | 77 | 1.80 | $1,025,608 | $206,629 |
| 2023 | 1,419 | 2,774 | 77 | 1.62 | $1,009,246 | $218,185 |
| 2022 | 1,513 | 2,892 | 76 | 1.67 | $916,330 | $217,089 |
| 2021 | 1,589 | 3,329 | 76 | 1.65 | $1,134,828 | $265,628 |
| 2020 | 1,301 | 2,708 | 76 | 1.69 | $890,722 | $217,512 |
| 2019 | 1,638 | 3,417 | 76 | 1.77 | $1,080,389 | $245,598 |
| 2018 | 1,648 | 3,401 | 76 | 1.73 | $1,071,770 | $256,777 |
| 2017 | 1,697 | 3,512 | 76 | 1.62 | $958,360 | $230,860 |
| 2016 | 1,659 | 3,901 | 76 | 1.67 | $965,245 | $237,429 |
| 2015 | 1,505 | 4,494 | 76 | 1.59 | $891,347 | $222,520 |
| 2014 | 1,121 | 4,705 | 76 | 1.31 | $854,836 | $218,304 |
| 2013 | 991 | 2,941 | 76 | 1.45 | $904,874 | $215,604 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 29 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 173 | $32,941 | $189 |
| Long return visit (40+ min) | 131 | $30,000 | $160 |
| Return visit (30+ min) | 201 | $28,707 | $106 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $11,556 | $462 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | $10,867 | $453 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $10,166 | $236 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $9,780 | $106 |
| Critical care, first 30-74 minutes | 20 | $7,524 | $175 |
| New patient visit (60+ min) | 28 | $5,555 | $198 |
| Injection, regadenoson, 0.1 mg | 28 | $4,832 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,518 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 584 | $4,274 | $6 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,222 | $151 |
| Transitional care management services for problem of high complexity | 12 | $3,515 | $270 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 235 | $2,941 | $12 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $2,640 | $220 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $2,534 | $141 |
| Programming of dual lead pacemaker system | 18 | $2,312 | $77 |
| Short return visit (20+ min) | 28 | $2,311 | $77 |
| Heart muscle strain imaging | 54 | $2,109 | $39 |
| Injection, perflutren lipid microspheres, per ml | 24 | $2,047 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,541 | $62 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 50 | $1,153 | $23 |
| 3d radiographic procedure | 30 | $744 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 63 | $727 | $11 |
| Heart rhythm recording of continous external ekg over 8-15 days | 49 | $607 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $461 | $26 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 23 | $402 | $9 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $361 | $24 |
2022: 28 services
| Long return visit (40+ min) | 171 | $35,271 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $26,315 | $183 |
| Return visit (30+ min) | 187 | $25,039 | $109 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 33 | $19,888 | $306 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $16,299 | $479 |
| Injection, regadenoson, 0.1 mg | 31 | $6,208 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $5,104 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,011 | $173 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 600 | $4,916 | $7 |
| New patient visit (60+ min) | 24 | $4,612 | $192 |
| Heart muscle strain imaging | 104 | $4,119 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 316 | $3,876 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $3,400 | $92 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $3,234 | $231 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 17 | $2,785 | $164 |
| Programming of dual lead pacemaker system | 19 | $2,404 | $83 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $2,339 | $195 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 33 | $2,024 | $61 |
| Short return visit (20+ min) | 20 | $1,732 | $79 |
| 3d radiographic procedure | 72 | $1,673 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 65 | $1,572 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $1,459 | $58 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,194 | $70 |
| Heart rhythm recording of continous external ekg over 8-15 days | 58 | $843 | $15 |
| Administration of influenza virus vaccine | 17 | $624 | $37 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $578 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 51 | $570 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $334 | $26 |
2021: 35 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 180 | $34,757 | $193 |
| Return visit (30+ min) | 182 | $25,271 | $114 |
| Long return visit (40+ min) | 110 | $24,266 | $160 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 41 | $21,136 | $503 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $12,717 | $424 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,607 | $177 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 41 | $10,530 | $125 |
| Injection, regadenoson, 0.1 mg | 40 | $7,700 | None |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 13 | $7,414 | $570 |
| Critical care, first 30-74 minutes | 14 | $6,816 | $195 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $5,959 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $5,839 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $5,594 | $233 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 411 | $5,356 | $13 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 33 | $5,346 | $162 |
| Telephone medical discussion with physician, 21-30 minutes | 48 | $4,804 | $86 |
| Heart muscle strain imaging | 107 | $4,462 | $42 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 534 | $4,399 | $7 |
| Transitional care management services for problem of high complexity | 16 | $4,308 | $269 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 53 | $4,109 | $76 |
| New patient visit (60+ min) | 17 | $3,444 | $203 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $2,681 | $192 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $2,454 | $189 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 39 | $2,447 | $61 |
| Short return visit (20+ min) | 30 | $2,387 | $77 |
| 3d radiographic procedure with computerized image postprocessing | 28 | $1,987 | $71 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 72 | $1,783 | $24 |
| Programming of dual lead pacemaker system | 15 | $1,658 | $79 |
| 3d radiographic procedure | 70 | $1,594 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,133 | $67 |
| Heart rhythm recording of continous external ekg over 8-15 days | 69 | $1,082 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 88 | $1,050 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 38 | $1,038 | $23 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 18 | $1,031 | $30 |
| Blood test, clotting time | 22 | $120 | $4 |
2020: 33 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 154 | $30,513 | $198 |
| Return visit (30+ min) | 237 | $29,046 | $90 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $15,137 | $505 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,369 | $432 |
| Critical care, first 30-74 minutes | 11 | $9,607 | $200 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $8,254 | $229 |
| Telephone medical discussion with physician, 21-30 minutes | 67 | $7,930 | $104 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $5,904 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 343 | $5,499 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $5,236 | $95 |
| Injection, regadenoson, 0.1 mg | 27 | $5,091 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $5,065 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 66 | $4,503 | $65 |
| Long return visit (40+ min) | 27 | $4,067 | $140 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 48 | $4,059 | $83 |
| Short return visit (20+ min) | 52 | $4,017 | $69 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 24 | $4,007 | $160 |
| 3d radiographic procedure with computerized image postprocessing | 50 | $3,581 | $72 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,290 | $219 |
| New patient visit (60+ min) | 16 | $3,104 | $194 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,904 | $264 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 322 | $2,860 | $8 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $2,547 | $73 |
| Heart muscle strain imaging | 53 | $2,211 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 33 | $2,067 | $63 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 83 | $2,032 | $24 |
| Transitional care management services for problem of at least moderate complexity | 12 | $1,813 | $151 |
| External ekg recording for more than 48 hours up to 21 days | 62 | $1,671 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,667 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 76 | $917 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 26 | $642 | $19 |
| Blood test, clotting time | 52 | $356 | $4 |
| 3d radiographic procedure | 11 | $254 | $23 |
2019: 34 services
| Return visit (30+ min) | 323 | $55,873 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 138 | $27,812 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $15,048 | $502 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $10,843 | $226 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $10,782 | $449 |
| Critical care, first 30-74 minutes | 19 | $10,637 | $197 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 524 | $8,052 | $15 |
| Long return visit (40+ min) | 41 | $6,171 | $131 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $6,017 | $182 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $5,832 | $97 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 68 | $5,549 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,686 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 504 | $4,476 | $7 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 29 | $4,462 | $149 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 67 | $4,355 | $65 |
| Injection, regadenoson, 0.1 mg | 21 | $3,839 | None |
| 3d radiographic procedure with computerized image postprocessing | 49 | $3,402 | $69 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,024 | $252 |
| Transitional care management services for problem of at least moderate complexity | 19 | $2,935 | $154 |
| New patient visit (60+ min) | 16 | $2,616 | $163 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 36 | $2,106 | $58 |
| Influenza vaccine split virus, preservative free | 36 | $1,940 | $54 |
| Programming of dual lead pacemaker system | 19 | $1,761 | $59 |
| Short return visit (20+ min) | 28 | $1,635 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,508 | $66 |
| External ekg recording for more than 48 hours up to 21 days | 53 | $1,462 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 54 | $1,314 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 75 | $861 | $11 |
| Administration of influenza virus vaccine | 36 | $726 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $526 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $508 | $25 |
| Blood test, clotting time | 59 | $458 | $4 |
| 3d radiographic procedure | 19 | $434 | $23 |
| Ultrasound of heart, follow-up | 11 | $300 | $23 |
2018: 32 services
| Return visit (30+ min) | 307 | $47,586 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 161 | $32,469 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 40 | $20,159 | $504 |
| Long return visit (40+ min) | 96 | $16,193 | $124 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 55 | $12,172 | $221 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $12,089 | $378 |
| Critical care, first 30-74 minutes | 19 | $10,680 | $194 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 40 | $7,633 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,273 | $173 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 450 | $6,734 | $14 |
| New patient visit (60+ min) | 37 | $6,619 | $179 |
| Injection, regadenoson, 0.1 mg | 36 | $6,384 | None |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,210 | $565 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,185 | $86 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 572 | $4,742 | $7 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $4,344 | $155 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $4,040 | $238 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 49 | $3,990 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 55 | $3,692 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 47 | $2,894 | $62 |
| Transitional care management services for problem of high complexity | 13 | $2,848 | $219 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $2,682 | $192 |
| Transitional care management services for problem of at least moderate complexity | 12 | $1,864 | $155 |
| External ekg recording for more than 48 hours up to 21 days | 55 | $1,556 | $27 |
| 3d radiographic procedure with computerized image postprocessing | 21 | $1,429 | $68 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 55 | $1,382 | $24 |
| Programming of dual lead pacemaker system | 15 | $1,142 | $50 |
| Influenza vaccine split virus, preservative free | 22 | $963 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 80 | $920 | $11 |
| Administration of influenza virus vaccine | 24 | $607 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $606 | $18 |
| Blood test, clotting time | 57 | $537 | $5 |
2017: 34 services
| Return visit (30+ min) | 313 | $47,674 | $87 |
| Long return visit (40+ min) | 100 | $15,310 | $122 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $15,224 | $411 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,619 | $175 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $12,205 | $488 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 17 | $9,951 | $553 |
| Critical care, first 30-74 minutes | 20 | $9,848 | $189 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 615 | $9,144 | $14 |
| New patient visit (60+ min) | 46 | $7,692 | $167 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 78 | $6,774 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $6,028 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 451 | $5,585 | $11 |
| Transitional care management services for problem of high complexity | 23 | $4,907 | $213 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $4,805 | $240 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 25 | $4,771 | $95 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 29 | $4,105 | $142 |
| Injection, regadenoson, 0.1 mg | 22 | $3,295 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 38 | $2,998 | $79 |
| Transitional care management services for problem of at least moderate complexity | 18 | $2,722 | $151 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 17 | $2,721 | $160 |
| Influenza vaccine split virus, preservative free | 57 | $2,507 | $44 |
| External ekg recording for more than 48 hours up to 21 days | 70 | $1,899 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $1,890 | $61 |
| Administration of influenza virus vaccine | 58 | $1,803 | $31 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,679 | $58 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 70 | $1,677 | $24 |
| Programming of dual lead pacemaker system | 18 | $1,564 | $50 |
| Blood test, clotting time | 121 | $1,468 | $5 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 16 | $1,297 | $81 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 54 | $1,130 | $17 |
| Hospital observation care on day of discharge | 14 | $911 | $65 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 79 | $911 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $308 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $175 | $13 |
2016: 33 services
| Return visit (30+ min) | 345 | $54,110 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $22,456 | $449 |
| New patient visit (60+ min) | 72 | $12,180 | $169 |
| Long return visit (40+ min) | 75 | $11,459 | $125 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $10,605 | $461 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 48 | $9,160 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $8,936 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,489 | $166 |
| Critical care, first 30-74 minutes | 18 | $7,192 | $189 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 484 | $7,075 | $14 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 26 | $6,347 | $244 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $5,035 | $180 |
| Transitional care management services for problem of high complexity | 22 | $5,014 | $209 |
| Injection, regadenoson, 0.1 mg | 33 | $4,815 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 534 | $4,657 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 79 | $4,366 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 60 | $3,785 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $3,149 | $225 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,723 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,604 | $62 |
| Short return visit (20+ min) | 33 | $2,012 | $54 |
| Blood test, clotting time | 147 | $1,969 | $5 |
| Transitional care management services for problem of at least moderate complexity | 13 | $1,933 | $149 |
| Programming of dual lead pacemaker system | 20 | $1,515 | $49 |
| Hospital observation care on day of discharge | 22 | $1,467 | $64 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $1,202 | $80 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $971 | $14 |
| Influenza vaccine split virus, preservative free | 24 | $877 | $37 |
| External ekg recording for more than 48 hours up to 21 days | 31 | $861 | $28 |
| Administration of influenza virus vaccine | 28 | $838 | $30 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 31 | $741 | $24 |
| Programming of single lead pacemaker system | 12 | $689 | $41 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $248 | $13 |
2015: 30 services
| Return visit (30+ min) | 335 | $56,924 | $91 |
| Long return visit (40+ min) | 104 | $16,611 | $125 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 23 | $11,421 | $497 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $11,254 | $469 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,767 | $175 |
| New patient visit (60+ min) | 45 | $8,469 | $188 |
| Transitional care management services for problem of high complexity | 34 | $8,313 | $219 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 500 | $7,523 | $15 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 23 | $6,073 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $5,939 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,308 | $54 |
| Short return visit (20+ min) | 63 | $4,186 | $57 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $4,065 | $185 |
| Blood test, clotting time | 195 | $4,030 | $5 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $4,016 | $251 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 415 | $3,667 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 121 | $3,550 | $17 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,455 | $266 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,201 | $65 |
| Transitional care management services for problem of at least moderate complexity | 20 | $3,002 | $150 |
| Programming of dual lead pacemaker system | 23 | $2,098 | $54 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $2,093 | $68 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 22 | $1,909 | $87 |
| Hospital observation care on day of discharge | 12 | $800 | $67 |
| Programming of single lead pacemaker system | 13 | $736 | $46 |
| Influenza vaccine split virus, preservative free | 19 | $676 | $36 |
| Administration of influenza virus vaccine | 20 | $602 | $30 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 19 | $526 | None |
| Ultrasound of heart, follow-up | 12 | $269 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $139 | $13 |
2014: 29 services
| Return visit (30+ min) | 366 | $58,491 | $88 |
| Long return visit (40+ min) | 127 | $18,305 | $118 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 35 | $16,263 | $465 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $12,050 | $416 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 35 | $8,950 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,758 | $172 |
| Transitional care management services for problem of high complexity | 31 | $7,467 | $207 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 170 | $7,417 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 490 | $7,094 | $14 |
| Critical care, first 30-74 minutes | 14 | $6,158 | $187 |
| New patient visit (60+ min) | 32 | $5,512 | $172 |
| Blood test, clotting time | 189 | $4,717 | $5 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,325 | $88 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $4,178 | $232 |
| Short return visit (20+ min) | 61 | $4,019 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $3,050 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,542 | $61 |
| Transitional care management services for problem of at least moderate complexity | 17 | $2,503 | $147 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 40 | $2,491 | $62 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 29 | $2,307 | None |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,250 | $188 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $2,161 | $166 |
| Programming of dual lead pacemaker system | 22 | $1,861 | $50 |
| New patient visit (45+ min) | 14 | $1,708 | $122 |
| Influenza vaccine split virus, preservative free | 39 | $1,274 | $33 |
| Administration of influenza virus vaccine | 42 | $1,228 | $29 |
| Programming of single lead pacemaker system | 16 | $970 | $44 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $888 | $55 |
| Hospital discharge day management, 30 minutes or less | 13 | $825 | $63 |
2013: 30 services
| Return visit (30+ min) | 358 | $58,272 | $85 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 38 | $18,006 | $346 |
| Critical care, first 30-74 minutes | 26 | $14,598 | $185 |
| Long return visit (40+ min) | 93 | $12,565 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,132 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | $8,626 | $52 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $8,262 | $459 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 64 | $8,179 | $60 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 38 | $7,544 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 389 | $6,044 | $15 |
| New patient visit (60+ min) | 34 | $5,486 | $161 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 107 | $4,449 | $19 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $4,074 | $291 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 23 | $3,578 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,122 | $87 |
| Short return visit (20+ min) | 49 | $3,107 | $58 |
| New patient visit (45+ min) | 19 | $2,701 | $142 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 43 | $2,613 | $59 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,576 | $234 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 29 | $2,497 | None |
| Blood test, clotting time | 122 | $1,788 | $5 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,774 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,729 | $115 |
| Programming of dual lead pacemaker system | 18 | $1,148 | $50 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $907 | $60 |
| Hospital discharge day management, 30 minutes or less | 14 | $884 | $59 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $813 | $58 |
| Programming of single lead pacemaker system | 12 | $670 | $45 |
| Ultrasound of heart, follow-up | 11 | $259 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $248 | $12 |
Medicaid work
$6,237 in 2024
Medicaid paid $6,237 for 637 billed services this clinician did in 2024, up to 141 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 619 | $5,624 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 18 | $613 |
| 2024 | 637 | 2 | 141 | $6,237 |
| 2023 | 770 | 1 | 191 | $6,104 |
| 2022 | 624 | 1 | 178 | $5,055 |
| 2021 | 593 | 1 | 140 | $4,212 |
| 2020 | 312 | 1 | 108 | $2,339 |
| 2019 | 439 | 2 | 141 | $2,591 |
| 2018 | 523 | 2 | 122 | $3,211 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 770 | $6,104 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 624 | $5,055 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 593 | $4,212 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 312 | $2,339 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 425 | $2,493 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $98 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 511 | $3,206 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $4 |
Drugs they prescribed that Part D paid
$655,848
Pharmacies billed $655,848 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,127) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
2,775 generic and 352 brand-name prescriptions · $655,848 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 181 | $291,299 | $1,609 |
| Entresto | 39 | $68,966 | $1,768 |
| Jardiance | 28 | $45,041 | $1,609 |
| Xarelto | 23 | $28,088 | $1,221 |
| Multaq | 11 | $18,229 | $1,657 |
See all 40 drugs
| Eliquis | 181 | $291,299 | $1,609 |
| Entresto | 39 | $68,966 | $1,768 |
| Jardiance | 28 | $45,041 | $1,609 |
| Xarelto | 23 | $28,088 | $1,221 |
| Multaq | 11 | $18,229 | $1,657 |
| Dabigatran Etexilate | 14 | $6,686 | $478 |
| Atorvastatin | 455 | $4,575 | $10 |
| Metoprolol | 263 | $3,111 | $12 |
| Ezetimibe | 44 | $3,070 | $70 |
| Rosuvastatin | 185 | $2,989 | $16 |
| Carvedilol | 256 | $2,158 | $8 |
| Losartan | 168 | $2,131 | $13 |
| Clopidogrel | 179 | $1,840 | $10 |
| Isosorbide Mononitrate Er | 69 | $1,524 | $22 |
| Diltiazem 24hr Er (Cd) | 25 | $1,404 | $56 |
| Amlodipine Besylate | 188 | $1,120 | $6 |
| Lisinopril | 122 | $964 | $8 |
| Furosemide | 108 | $784 | $7 |
| Digoxin | 29 | $739 | $25 |
| Metoprolol | 72 | $691 | $10 |
| Valsartan | 20 | $669 | $33 |
| Fenofibrate | 27 | $553 | $20 |
| Spironolactone | 49 | $541 | $11 |
| Pravastatin | 44 | $507 | $12 |
| Pantoprazole | 31 | $498 | $16 |
| Amiodarone | 16 | $433 | $27 |
| Benazepril | 18 | $398 | $22 |
| Potassium Chloride | 19 | $377 | $20 |
| Nebivolol | 13 | $311 | $24 |
| Labetalol | 11 | $308 | $28 |
| Olmesartan Medoxomil | 15 | $266 | $18 |
| Hydrochlorothiazide | 64 | $255 | $4 |
| Sotalol | 12 | $241 | $20 |
| Nitroglycerin | 26 | $204 | $8 |
| Simvastatin | 11 | $184 | $17 |
| Warfarin | 13 | $165 | $13 |
| Famotidine | 11 | $86 | $8 |
| Metformin | 16 | $74 | $5 |
| Atenolol | 13 | $65 | $5 |
| Irbesartan | 11 | $60 | $5 |
Year by year
| 2024 | 3,127 | 376 | 0% (0) | 11% | $655,848 |
| 2023 | 3,199 | 363 | 0% (0) | 10% | $532,210 |
| 2022 | 3,396 | 359 | 0% (0) | None | $484,092 |
| 2021 | 3,170 | 361 | 0% (0) | 10% | $358,674 |
| 2020 | 2,985 | 341 | 0% (0) | 11% | $326,106 |
| 2019 | 2,751 | 332 | 0% (0) | 10% | $252,789 |
| 2018 | 2,662 | 346 | 0% (0) | 11% | $200,685 |
| 2017 | 2,652 | 348 | 0% (0) | 15% | $184,879 |
| 2016 | 2,694 | 353 | 0% (0) | 18% | $188,331 |
| 2015 | 2,800 | 356 | 0% (0) | 16% | $154,240 |
| 2014 | 2,860 | 353 | None | 17% | $167,837 |
| 2013 | 2,540 | 302 | 0% (0) | None | $143,815 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Eliquis | 172 | $274,992 | $1,599 |
| Xarelto | 38 | $50,937 | $1,340 |
| Entresto | 26 | $42,297 | $1,627 |
| Jardiance | 23 | $33,913 | $1,474 |
| Atorvastatin | 436 | $5,817 | $13 |
| Metoprolol | 259 | $4,481 | $17 |
| Carvedilol | 268 | $3,578 | $13 |
| Isosorbide Mononitrate Er | 93 | $3,379 | $36 |
| Clopidogrel | 167 | $3,186 | $19 |
| Rosuvastatin | 146 | $2,903 | $20 |
| Ezetimibe | 30 | $2,789 | $93 |
| Losartan | 195 | $2,737 | $14 |
| Amlodipine Besylate | 186 | $2,477 | $13 |
| Diltiazem 24hr Er (Cd) | 30 | $1,808 | $60 |
| Digoxin | 45 | $1,629 | $36 |
| Lisinopril | 134 | $1,583 | $12 |
| Furosemide | 153 | $1,214 | $8 |
| Valsartan | 18 | $1,157 | $64 |
| Metoprolol | 69 | $897 | $13 |
| Pantoprazole | 37 | $849 | $23 |
| Potassium Chloride | 27 | $825 | $31 |
| Fenofibrate | 26 | $817 | $31 |
| Spironolactone | 48 | $665 | $14 |
| Labetalol | 11 | $636 | $58 |
| Benazepril | 24 | $604 | $25 |
| Pravastatin | 49 | $573 | $12 |
| Hydralazine | 14 | $512 | $37 |
| Amiodarone | 17 | $446 | $26 |
| Hydrochlorothiazide | 65 | $417 | $6 |
| Sotalol | 12 | $412 | $34 |
| Nitroglycerin | 28 | $355 | $13 |
| Warfarin | 14 | $306 | $22 |
| Irbesartan | 13 | $269 | $21 |
| Atenolol | 11 | $223 | $20 |
| Simvastatin | 15 | $213 | $14 |
| Metformin | 20 | $156 | $8 |
| Lovastatin | 14 | $100 | $7 |
2022: 42 drugs
| Eliquis | 173 | $248,573 | $1,437 |
| Xarelto | 28 | $35,227 | $1,258 |
| Pradaxa | 25 | $27,148 | $1,086 |
| Entresto | 18 | $25,626 | $1,424 |
| Jardiance | 16 | $17,458 | $1,091 |
| Praluent | 14 | $8,986 | $642 |
| Atorvastatin | 464 | $6,262 | $13 |
| Metoprolol | 249 | $4,861 | $20 |
| Amiodarone | 36 | $4,632 | $129 |
| Isosorbide Mononitrate Er | 115 | $4,243 | $37 |
| Carvedilol | 259 | $4,082 | $16 |
| Clopidogrel | 192 | $3,635 | $19 |
| Rosuvastatin | 113 | $3,188 | $28 |
| Ezetimibe | 27 | $2,592 | $96 |
| Digoxin | 51 | $2,286 | $45 |
| Losartan | 217 | $2,245 | $10 |
| Diltiazem 24hr Er (Cd) | 37 | $2,083 | $56 |
| Amlodipine Besylate | 209 | $2,048 | $10 |
| Lisinopril | 159 | $1,859 | $12 |
| Pantoprazole | 53 | $1,553 | $29 |
| Isosorbide Dinitrate | 11 | $1,519 | $138 |
| Fenofibrate | 27 | $1,407 | $52 |
| Valsartan | 14 | $1,236 | $88 |
| Labetalol | 11 | $1,135 | $103 |
| Furosemide | 132 | $1,125 | $9 |
| Metoprolol | 81 | $993 | $12 |
| Bumetanide | 12 | $891 | $74 |
| Pravastatin | 55 | $738 | $13 |
| Benazepril | 19 | $646 | $34 |
| Nitroglycerin | 38 | $600 | $16 |
| Hydralazine | 13 | $592 | $46 |
| Sotalol | 16 | $525 | $33 |
| Potassium Chloride | 18 | $420 | $23 |
| Hydrochlorothiazide | 70 | $405 | $6 |
| Spironolactone | 36 | $385 | $11 |
| Ramipril | 16 | $317 | $20 |
| Warfarin | 22 | $215 | $10 |
| Simvastatin | 27 | $206 | $8 |
| Irbesartan | 14 | $174 | $12 |
| Atenolol | 16 | $174 | $11 |
| Lovastatin | 13 | $90 | $7 |
| Metformin | 16 | $52 | $3 |
2021: 36 drugs
| Eliquis | 134 | $187,708 | $1,401 |
| Pradaxa | 18 | $23,907 | $1,328 |
| Xarelto | 13 | $18,549 | $1,427 |
| Atorvastatin | 431 | $6,880 | $16 |
| Isosorbide Mononitrate Er | 139 | $6,148 | $44 |
| Metoprolol | 249 | $5,574 | $22 |
| Clopidogrel | 218 | $4,576 | $21 |
| Carvedilol | 261 | $4,108 | $16 |
| Ezetimibe | 33 | $3,232 | $98 |
| Rosuvastatin | 85 | $2,641 | $31 |
| Losartan | 191 | $2,566 | $13 |
| Amiodarone | 25 | $2,471 | $99 |
| Digoxin | 45 | $2,114 | $47 |
| Diltiazem 24hr Er (Cd) | 24 | $1,936 | $81 |
| Prasugrel | 20 | $1,503 | $75 |
| Amlodipine Besylate | 148 | $1,460 | $10 |
| Pantoprazole | 54 | $1,310 | $24 |
| Fenofibrate | 17 | $1,243 | $73 |
| Potassium Chloride | 33 | $1,194 | $36 |
| Furosemide | 140 | $1,132 | $8 |
| Pravastatin | 59 | $1,084 | $18 |
| Lisinopril | 135 | $1,065 | $8 |
| Metoprolol | 83 | $985 | $12 |
| Warfarin | 19 | $588 | $31 |
| Nitroglycerin | 37 | $577 | $16 |
| Benazepril | 18 | $559 | $31 |
| Hydrochlorothiazide | 75 | $477 | $6 |
| Tamsulosin | 18 | $406 | $23 |
| Atenolol | 23 | $362 | $16 |
| Hydralazine | 20 | $339 | $17 |
| Spironolactone | 21 | $264 | $13 |
| Famotidine | 13 | $246 | $19 |
| Simvastatin | 31 | $161 | $5 |
| Ramipril | 12 | $115 | $10 |
| Metformin | 17 | $68 | $4 |
| Amoxicillin | 14 | $18 | $1 |
2020: 40 drugs
| Eliquis | 109 | $144,725 | $1,328 |
| Xarelto | 19 | $23,409 | $1,232 |
| Pradaxa | 17 | $21,626 | $1,272 |
| Atorvastatin | 375 | $6,942 | $19 |
| Isosorbide Mononitrate Er | 146 | $6,438 | $44 |
| Metoprolol | 207 | $4,941 | $24 |
| Rosuvastatin | 78 | $4,898 | $63 |
| Diltiazem 24hr Er (Cd) | 31 | $4,400 | $142 |
| Clopidogrel | 171 | $3,382 | $20 |
| Ranolazine Er | 14 | $3,171 | $226 |
| Carvedilol | 240 | $3,145 | $13 |
| Ezetimibe | 40 | $2,733 | $68 |
| Isosorbide Dinitrate | 21 | $2,315 | $110 |
| Digoxin | 39 | $2,131 | $55 |
| Losartan | 147 | $2,130 | $14 |
| Amiodarone | 27 | $1,848 | $68 |
| Pravastatin | 67 | $1,720 | $26 |
| Labetalol | 11 | $1,695 | $154 |
| Potassium Chloride | 42 | $1,567 | $37 |
| Diltiazem | 14 | $1,485 | $106 |
| Pantoprazole | 53 | $1,457 | $27 |
| Prasugrel | 27 | $1,415 | $52 |
| Valsartan | 14 | $1,345 | $96 |
| Amlodipine Besylate | 144 | $1,331 | $9 |
| Furosemide | 145 | $1,066 | $7 |
| Lisinopril | 124 | $1,062 | $9 |
| Fenofibrate | 12 | $825 | $69 |
| Metoprolol | 76 | $822 | $11 |
| Hydralazine | 21 | $805 | $38 |
| Warfarin | 23 | $665 | $29 |
| Nitroglycerin | 25 | $501 | $20 |
| Hydrochlorothiazide | 68 | $400 | $6 |
| Atenolol | 27 | $302 | $11 |
| Benazepril | 21 | $302 | $14 |
| Levothyroxine | 11 | $295 | $27 |
| Spironolactone | 23 | $290 | $13 |
| Simvastatin | 29 | $234 | $8 |
| Famotidine | 16 | $224 | $14 |
| Metformin | 22 | $217 | $10 |
| Lovastatin | 17 | $215 | $13 |
2019: 36 drugs
| Eliquis | 82 | $93,036 | $1,135 |
| Pradaxa | 16 | $20,104 | $1,257 |
| Xarelto | 15 | $19,115 | $1,274 |
| Atorvastatin | 321 | $7,380 | $23 |
| Metoprolol | 212 | $6,599 | $31 |
| Isosorbide Mononitrate Er | 132 | $6,496 | $49 |
| Rosuvastatin | 71 | $5,743 | $81 |
| Diltiazem 24hr Er (Cd) | 31 | $4,290 | $138 |
| Carvedilol | 250 | $3,530 | $14 |
| Clopidogrel | 153 | $2,818 | $18 |
| Digoxin | 44 | $2,632 | $60 |
| Labetalol | 18 | $2,610 | $145 |
| Prasugrel | 24 | $2,408 | $100 |
| Pravastatin | 75 | $2,384 | $32 |
| Ezetimibe | 40 | $1,997 | $50 |
| Isosorbide Dinitrate | 15 | $1,926 | $128 |
| Losartan | 118 | $1,869 | $16 |
| Valsartan | 14 | $1,434 | $102 |
| Amlodipine Besylate | 136 | $1,173 | $9 |
| Furosemide | 131 | $1,103 | $8 |
| Amiodarone | 26 | $1,062 | $41 |
| Pantoprazole | 42 | $1,054 | $25 |
| Warfarin | 45 | $1,013 | $23 |
| Potassium Chloride | 35 | $1,011 | $29 |
| Nitroglycerin | 43 | $982 | $23 |
| Lisinopril | 115 | $925 | $8 |
| Metoprolol | 79 | $713 | $9 |
| Cilostazol | 13 | $582 | $45 |
| Digox | 11 | $478 | $43 |
| Hydralazine | 14 | $427 | $31 |
| Hydrochlorothiazide | 51 | $425 | $8 |
| Simvastatin | 31 | $343 | $11 |
| Benazepril | 16 | $314 | $20 |
| Spironolactone | 16 | $233 | $15 |
| Lovastatin | 19 | $214 | $11 |
| Atenolol | 21 | $97 | $5 |
2018: 37 drugs
| Eliquis | 52 | $42,739 | $822 |
| Xarelto | 20 | $22,384 | $1,119 |
| Pradaxa | 18 | $20,153 | $1,120 |
| Ranexa | 17 | $9,584 | $564 |
| Metoprolol | 208 | $7,264 | $35 |
| Atorvastatin | 302 | $6,726 | $22 |
| Isosorbide Mononitrate Er | 113 | $6,294 | $56 |
| Ezetimibe | 28 | $4,187 | $150 |
| Diltiazem 24hr Er (Cd) | 19 | $4,164 | $219 |
| Rosuvastatin | 44 | $3,400 | $77 |
| Clopidogrel | 185 | $3,378 | $18 |
| Digoxin | 39 | $2,705 | $69 |
| Pravastatin | 94 | $2,499 | $27 |
| Labetalol | 21 | $2,202 | $105 |
| Carvedilol | 201 | $1,825 | $9 |
| Losartan | 112 | $1,591 | $14 |
| Warfarin | 54 | $1,571 | $29 |
| Valsartan | 26 | $1,531 | $59 |
| Cartia Xt | 19 | $1,342 | $71 |
| Prasugrel | 14 | $1,260 | $90 |
| Nitroglycerin | 38 | $1,216 | $32 |
| Potassium Chloride | 34 | $1,045 | $31 |
| Lisinopril | 132 | $1,037 | $8 |
| Amlodipine Besylate | 125 | $976 | $8 |
| Furosemide | 144 | $872 | $6 |
| Digox | 14 | $783 | $56 |
| Pantoprazole | 37 | $757 | $20 |
| Metoprolol | 74 | $617 | $8 |
| Amiodarone | 18 | $554 | $31 |
| Cilostazol | 15 | $444 | $30 |
| Simvastatin | 41 | $443 | $11 |
| Hydrochlorothiazide | 51 | $426 | $8 |
| Lovastatin | 29 | $375 | $13 |
| Benazepril | 18 | $172 | $10 |
| Spironolactone | 12 | $164 | $14 |
| Atenolol | 17 | $67 | $4 |
| Donepezil | 11 | $32 | $3 |
2017: 36 drugs
| Eliquis | 32 | $26,181 | $818 |
| Pradaxa | 15 | $16,059 | $1,071 |
| Xarelto | 19 | $12,989 | $684 |
| Welchol | 11 | $10,284 | $935 |
| Metoprolol | 216 | $8,774 | $41 |
| Ranexa | 12 | $7,405 | $617 |
| Atorvastatin | 249 | $6,525 | $26 |
| Isosorbide Mononitrate Er | 103 | $5,442 | $53 |
| Digoxin | 56 | $3,899 | $70 |
| Rosuvastatin | 32 | $3,459 | $108 |
| Clopidogrel | 193 | $3,399 | $18 |
| Diltiazem 24hr Er | 26 | $3,383 | $130 |
| Pravastatin | 90 | $2,515 | $28 |
| Valsartan | 30 | $2,355 | $79 |
| Warfarin | 78 | $1,927 | $25 |
| Carvedilol | 191 | $1,791 | $9 |
| Cartia Xt | 33 | $1,714 | $52 |
| Losartan | 100 | $1,394 | $14 |
| Digox | 13 | $1,176 | $90 |
| Labetalol | 16 | $1,077 | $67 |
| Lisinopril | 159 | $1,036 | $7 |
| Fenofibrate | 11 | $967 | $88 |
| Amiodarone | 25 | $957 | $38 |
| Furosemide | 140 | $876 | $6 |
| Potassium Chloride | 30 | $873 | $29 |
| Amlodipine Besylate | 149 | $862 | $6 |
| Nitroglycerin | 33 | $740 | $22 |
| Pantoprazole | 41 | $704 | $17 |
| Metoprolol | 81 | $610 | $8 |
| Lovastatin | 28 | $435 | $16 |
| Cilostazol | 11 | $373 | $34 |
| Simvastatin | 48 | $373 | $8 |
| Hydralazine | 14 | $335 | $24 |
| Hydrochlorothiazide | 45 | $332 | $7 |
| Spironolactone | 20 | $296 | $15 |
| Benazepril | 23 | $245 | $11 |
2016: 39 drugs
| Eliquis | 21 | $17,807 | $848 |
| Pradaxa | 24 | $13,849 | $577 |
| Xarelto | 19 | $13,826 | $728 |
| Zetia | 21 | $12,654 | $603 |
| Welchol | 13 | $9,170 | $705 |
| Ranexa | 14 | $8,361 | $597 |
| Metoprolol | 216 | $7,405 | $34 |
| Diltiazem 24hr Er | 38 | $6,656 | $175 |
| Atorvastatin | 229 | $5,984 | $26 |
| Isosorbide Mononitrate Er | 107 | $4,508 | $42 |
| Clopidogrel | 224 | $4,425 | $20 |
| Lipitor | 11 | $3,387 | $308 |
| Digoxin | 55 | $3,238 | $59 |
| Valsartan | 23 | $2,418 | $105 |
| Pravastatin | 79 | $2,381 | $30 |
| Amiodarone | 27 | $2,339 | $87 |
| Carvedilol | 196 | $2,203 | $11 |
| Warfarin | 96 | $1,824 | $19 |
| Cartia Xt | 32 | $1,733 | $54 |
| Rosuvastatin | 11 | $1,726 | $157 |
| Losartan | 96 | $1,459 | $15 |
| Fenofibrate | 11 | $1,358 | $123 |
| Amlodipine Besylate | 164 | $1,260 | $8 |
| Digox | 22 | $1,166 | $53 |
| Potassium Chloride | 34 | $1,065 | $31 |
| Metoprolol | 94 | $862 | $9 |
| Furosemide | 140 | $777 | $6 |
| Lisinopril | 113 | $767 | $7 |
| Nitrostat | 25 | $670 | $27 |
| Hydralazine | 21 | $555 | $26 |
| Pantoprazole | 23 | $512 | $22 |
| Simvastatin | 52 | $488 | $9 |
| Lovastatin | 33 | $451 | $14 |
| Hydrochlorothiazide | 46 | $394 | $9 |
| Clonidine | 12 | $350 | $29 |
| Cilostazol | 11 | $296 | $27 |
| Benazepril | 19 | $197 | $10 |
| Spironolactone | 14 | $170 | $12 |
| Clindamycin | 12 | $42 | $4 |
2015: 39 drugs
| Pradaxa | 25 | $13,312 | $532 |
| Diovan | 15 | $9,734 | $649 |
| Xarelto | 11 | $8,085 | $735 |
| Metoprolol | 192 | $7,470 | $39 |
| Crestor | 15 | $6,756 | $450 |
| Diltiazem 24hr Er | 19 | $6,424 | $338 |
| Welchol | 11 | $5,523 | $502 |
| Atorvastatin | 213 | $5,273 | $25 |
| Clopidogrel | 216 | $3,728 | $17 |
| Pravastatin | 87 | $3,580 | $41 |
| Isosorbide Mononitrate Er | 123 | $3,556 | $29 |
| Valsartan | 14 | $2,534 | $181 |
| Carvedilol | 216 | $2,196 | $10 |
| Amiodarone | 16 | $2,121 | $133 |
| Warfarin | 114 | $2,107 | $18 |
| Digoxin | 27 | $2,041 | $76 |
| Losartan | 110 | $1,609 | $15 |
| Digox | 33 | $1,367 | $41 |
| Potassium Chloride | 47 | $1,346 | $29 |
| Fenofibrate | 11 | $1,291 | $117 |
| Cartia Xt | 23 | $1,149 | $50 |
| Amlodipine Besylate | 134 | $1,006 | $8 |
| Lisinopril | 115 | $887 | $8 |
| Nitrostat | 40 | $840 | $21 |
| Metoprolol | 104 | $827 | $8 |
| Furosemide | 186 | $774 | $4 |
| Simvastatin | 61 | $742 | $12 |
| Enalapril Maleate | 12 | $676 | $56 |
| Hydralazine | 20 | $618 | $31 |
| Pramipexole Dihydrochloride | 11 | $611 | $56 |
| Hydrochlorothiazide | 60 | $530 | $9 |
| Lovastatin | 42 | $463 | $11 |
| Pantoprazole | 25 | $435 | $17 |
| Cilostazol | 14 | $375 | $27 |
| Diltiazem Er | 12 | $345 | $29 |
| Benazepril | 23 | $258 | $11 |
| Spironolactone | 24 | $241 | $10 |
| Ranitidine | 17 | $137 | $8 |
| Atenolol | 22 | $86 | $4 |
2014: 42 drugs
| Diovan | 48 | $20,697 | $431 |
| Pradaxa | 33 | $15,672 | $475 |
| Metoprolol | 158 | $8,006 | $51 |
| Ranexa | 12 | $6,824 | $569 |
| Clopidogrel | 217 | $6,667 | $31 |
| Enoxaparin | 13 | $6,177 | $475 |
| Atorvastatin | 190 | $5,688 | $30 |
| Isosorbide Mononitrate Er | 130 | $4,489 | $35 |
| Welchol | 11 | $4,392 | $399 |
| Pravastatin | 99 | $4,203 | $42 |
| Carvedilol | 227 | $3,214 | $14 |
| Diltiazem 24hr Er | 12 | $2,402 | $200 |
| Warfarin | 127 | $2,246 | $18 |
| Digoxin | 29 | $2,217 | $76 |
| Digox | 45 | $2,127 | $47 |
| Diltiazem 24hr Cd | 13 | $1,774 | $136 |
| Amiodarone | 25 | $1,749 | $70 |
| Losartan | 77 | $1,452 | $19 |
| Fenofibrate | 16 | $1,434 | $90 |
| Potassium Chloride | 36 | $1,344 | $37 |
| Simvastatin | 103 | $1,217 | $12 |
| Amlodipine Besylate | 119 | $1,187 | $10 |
| Lisinopril | 138 | $1,015 | $7 |
| Furosemide | 192 | $1,012 | $5 |
| Cilostazol | 17 | $905 | $53 |
| Hydralazine | 32 | $894 | $28 |
| Verapamil Er | 14 | $791 | $56 |
| Diltiazem Er | 15 | $783 | $52 |
| Nitrostat | 41 | $725 | $18 |
| Cartia Xt | 12 | $716 | $60 |
| Ranitidine | 23 | $641 | $28 |
| Pantoprazole | 18 | $627 | $35 |
| Metoprolol | 81 | $617 | $8 |
| Hydrochlorothiazide | 66 | $530 | $8 |
| Lovastatin | 31 | $521 | $17 |
| Benazepril | 32 | $483 | $15 |
| Spironolactone | 24 | $386 | $16 |
| Clonidine | 18 | $294 | $16 |
| Klor-Con 8 | 14 | $242 | $17 |
| Atenolol | 32 | $233 | $7 |
| Enalapril Maleate | 14 | $205 | $15 |
| Triamterene-Hydrochlorothiazid | 12 | $175 | $15 |
2013: 37 drugs
| Clopidogrel | 201 | $14,280 | $71 |
| Diovan | 45 | $12,821 | $285 |
| Pradaxa | 29 | $11,572 | $399 |
| Ranexa | 19 | $10,492 | $552 |
| Metoprolol | 121 | $7,626 | $63 |
| Atorvastatin | 152 | $6,995 | $46 |
| Isosorbide Mononitrate Er | 120 | $3,915 | $33 |
| Welchol | 11 | $3,401 | $309 |
| Pravastatin | 116 | $3,204 | $28 |
| Carvedilol | 164 | $3,035 | $19 |
| Losartan | 78 | $2,519 | $32 |
| Simvastatin | 116 | $1,358 | $12 |
| Amlodipine Besylate | 112 | $1,230 | $11 |
| Warfarin | 64 | $1,192 | $19 |
| Potassium Chloride | 25 | $1,171 | $47 |
| Cartia Xt | 14 | $1,002 | $72 |
| Lisinopril | 130 | $938 | $7 |
| Furosemide | 175 | $906 | $5 |
| Amlodipine Besylate-Benazepril | 12 | $729 | $61 |
| Lovastatin | 29 | $718 | $25 |
| Metoprolol | 75 | $682 | $9 |
| Diltiazem Er | 13 | $643 | $49 |
| Hydrochlorothiazide | 76 | $550 | $7 |
| Ranitidine | 38 | $537 | $14 |
| Propranolol | 18 | $518 | $29 |
| Amiodarone | 24 | $452 | $19 |
| Atenolol | 44 | $440 | $10 |
| Digox | 35 | $415 | $12 |
| Hydralazine | 22 | $382 | $17 |
| Benazepril | 20 | $327 | $16 |
| Nitrostat | 26 | $320 | $12 |
| Triamterene-Hctz | 12 | $266 | $22 |
| Clonidine | 26 | $251 | $10 |
| Spironolactone | 25 | $244 | $10 |
| Klor-Con 8 | 16 | $242 | $15 |
| Enalapril Maleate | 15 | $180 | $12 |
| Digoxin | 19 | $179 | $9 |
Money from drug and device companies
$229 in 2025
| 2025 | 2 | 4 | None | $229 |
| 2024 | 1 | 1 | None | $28 |
| 2023 | 2 | 2 | None | $143 |
| 2022 | 2 | 23 | None | $3,440 |
| 2021 | 3 | 3 | None | $307 |
| 2020 | 1 | 1 | None | $105 |
| 2019 | 3 | 3 | None | $379 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aurora Ev-Icd Mri Surescan | $170 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $60 | 3 payments
|
See all 4 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-22 | Lifevest | $2 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-29 | Lifevest | $31 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-03 | Lifevest | $27 |
| Medtronic | Meals · 2025-03-27 | Aurora Ev-Icd Mri Surescan | $170 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $28
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $28 | 1 payment
|
2023: $143
| Medtronic | Micra | $100 | 1 payment
|
| Philips Electronics North America | (6572) Rotational | $43 | 1 payment
|
2022: $3,440
| Medtronic | Resolute Onyx | $3,320 | 21 payments
|
| Philips Electronics North America | (6574) Coronary Other | $120 | 2 payments
|
2021: $307
| Ablative Solutions | None | $125 | 1 payment
|
| Penumbra | Indigo System | $102 | 1 payment
|
| Philips Electronics North America | (6346) Intrasight Mobile | $80 | 1 payment
|
2020: $105
| Shockwave Medical | Vascular Lithotripsy | $105 | 1 payment
|
2019: $379
| Abbott Laboratories | Optis Coronary Imaging System | $179 | 1 payment
|
| Biotronik | None | $126 | 1 payment
|
| CathWorks | Ffrangio System | $74 | 1 payment
|
Professional record
- NPI
- 1952385403
- Licence
- CA A88330California A88330: Current · expires 2028-02-29
- Trained
- University of California, Davis School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2005-11-29
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.